A meeting of representatives of the national regulatory authorities of Central Asian countries was held on September 29–30 in Tashkent, Republic of Uzbekistan, organized by the United States Pharmacopeia (USP).
The event was attended by Chingiz Shukurov, Head of the Laboratory for Expertise and Quality Control of Medical and Pharmaceutical Products of the Analytical Expertise Center of the Ministry of Health of the Republic of Azerbaijan.
The main objective of the meeting was to discuss modern approaches and international practices in the field of quality control of medicinal products, facilitate the exchange of experience among the national regulatory authorities of Central Asian countries, and share information on modern analytical methods and technologies applied in quality control processes.
As part of the event, presentations were delivered on the activities of the United States Pharmacopeia, recent developments introduced by the Pharmacopeia, and approaches used in the quality control of medicinal products. Particular attention was paid to the importance of USP Reference Standards in assessing the quality parameters of medicinal products and ensuring the reliability of analytical results.
In addition, current global trends in the field of quality control of medicinal products, modern equipment and analytical methods used in laboratory testing, as well as issues related to their validation and verification, were discussed in detail. Participants were provided with information on modern laboratory approaches and methods applied to ensure the reliability of analytical processes and the accuracy of results.
Special attention was also given to the identification of potentially hazardous carcinogenic and mutagenic impurities in medicinal products. Presentations were delivered on the determination of such impurities using modern analytical methods, the assessment of their quantities, and approaches applied in the quality control process. Information was also provided on the approach of the United States Pharmacopeia in this field and the application of relevant analytical methods.
An important aspect of the meeting was the sharing of existing practices of Central Asian countries in the field of quality control of medicinal products. During the meeting, participants exchanged views on the areas of activity of national regulatory authorities, as well as approaches applied in laboratory control and analytical expertise.
The discussions held during the meeting were important in terms of ensuring the quality of medicinal products and improving quality control mechanisms, applying modern analytical methods, and studying international standards and approaches.
Such events contribute to the development of cooperation among national regulatory authorities, the study of advanced international practices, and the expansion of professional knowledge and experience sharing in the field of quality control of medicinal products.
